Integrative Traditional Chinese Medicine Strategies for Refractory Mycoplasma Pneumonia in Children: Clinical Challenges, Mechanisms, and Evidence-Based Insights
Abstract
Abstract: Respiratory Mycoplasma Pneumonia (RMPP) in pediatric populations presents a significant therapeutic challenge, particularly due to the rising prevalence of macrolide-resistant strains and dysregulated immune responses. Traditional Chinese Medicine (TCM) offers a complementary therapeutic approach, focusing on restoring balance by addressing both underlying deficiencies, such as Qi and Yin deficiency, and excessive pathogenic factors, including inflammatory mediators (“heat toxin” in TCM theory) and mucus hypersecretion (“phlegm accumulation”). Key TCM herbs, including Scutellaria baicalensis and Isatis indigotica, demonstrate direct antimicrobial activity against Mycoplasma pneumoniae and exert immunomodulatory effects by reducing pro-inflammatory cytokines (e.g, TNF-α, IL-1, IL-6) and promoting the resolution of phlegm and mucus. These actions not only target infection but also alleviate airway obstruction and support lung function. Formulas such as Ma Xing Shi Gan Tang and Lianhua Qingwen have shown clinical efficacy when used in conjunction with antibiotics, resulting in accelerated fever resolution, reduced inflammatory markers, and enhanced radiographic improvement. Integrated treatment strategies combining TCM with conventional therapies have been shown to shorten symptom duration, decrease inflammatory biomarkers, and potentially reduce the need for corticosteroids. However, while the clinical evidence supporting TCM in RMPP management is promising, further…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.